Scenic Biotech Funding: $31M Raised, Series A (2022)

Scenic Biotech funding overview

Scenic Biotech is based in Amsterdam, Netherlands. Scenic Biotech has raised $31M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2022. The round record for Scenic Biotech runs through 2022; nothing later has been disclosed. Investors on record include Eir Ventures, BioMedPartners, Vesalius Biocapital, Inkef Capital, BioGeneration Ventures, Oxford Science Enterprises. 6 distinct backers are named across the disclosed rounds.

Scenic Biotech at a glance

Total raised: $31M
Latest round: Series A
Latest round date: March 2022
Headquarters: Amsterdam, Netherlands
Notable investors: Eir Ventures, BioMedPartners, Vesalius Biocapital, Inkef Capital, BioGeneration Ventures, Oxford Science Enterprises

Frequently asked about Scenic Biotech funding

How much has Scenic Biotech raised?: Scenic Biotech has raised $31M in total disclosed funding across the rounds on record.
Who has invested in Scenic Biotech?: Eir Ventures, BioMedPartners, Vesalius Biocapital, Inkef Capital, BioGeneration Ventures, Oxford Science Enterprises are named among the investors backing Scenic Biotech.
What was the latest Scenic Biotech funding round?: The most recent disclosed round is a Series A, announced in March 2022.
Where is Scenic Biotech based?: Scenic Biotech is based in Amsterdam, Netherlands.
When did Scenic Biotech last raise?: The last disclosed Scenic Biotech round closed in March 2022 at Series A.

We update the Scenic Biotech record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Amsterdam and their backers are listed below.

Scenic Biotech Funding: $31M Raised, Series A (2022)

Scenic Biotech funding overview

Scenic Biotech at a glance

Frequently asked about Scenic Biotech funding

Companies related to Scenic Biotech (18)

Browse related funding lists (7)